Octave Ventures

Octave Ventures operates as a global venture capital firm, strategically investing in companies across deep technology and biotechnology sectors. The firm provides capital and operational guidance to early-stage ventures, accelerating the development of groundbreaking innovations. Its investment approach prioritizes long-term partnerships with founders addressing complex technical challenges in these specialized fields.

Michael S. Kim established the firm in 2018, founding Octave Ventures (US) to support transformative companies. Kim's insight centered on the potential within highly technical and scientific fields, recognizing the need for specialized capital and expertise. His background underpins the firm's strategic focus, enabling effective engagement with sophisticated technological and biological enterprises.

Octave Ventures partners with founders and entrepreneurial teams developing advanced solutions, from novel therapeutics to AI-driven industrial applications. The firm's vision is to catalyze progress, facilitating the commercialization of scientific discoveries that reshape industries and enhance global well-being. It seeks to build a portfolio profoundly contributing to the future of technology and human health.